Two Sigma Advisers
LUMO

Two Sigma Advisers’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Two Sigma Advisers’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,900
Closed -$90K – 2721
2024
Q1 		$90K Buy
31,900
+3,600
+13% +$10.7K ﹤0.01% 2308
2023
Q4 		$90K Buy
+28,300
New +$96.4K ﹤0.01% 2334
2021
Q1 		– Sell
-7,398
Closed -$264K – 2760
2020
Q4 		$264K Sell
7,398
-5,400
-42% -$93.1K ﹤0.01% 2077
2020
Q3 		$177K Sell
12,798
-500
-4% -$7.47K ﹤0.01% 2183
2020
Q2 		$219K Sell
13,298
-700
-5% -$8.34K ﹤0.01% 2220
2020
Q1 		$119K Sell
13,998
-580
-4% -$8.11K ﹤0.01% 2280
2019
Q4 		$332K Sell
14,578
-44
-0.3% -$628 ﹤0.01% 2032
2019
Q3 		$209K Sell
14,622
-1,311
-8% -$19.2K ﹤0.01% 2030
2019
Q2 		$212K Buy
15,933
+933
+6% +$14.1K ﹤0.01% 2113
2019
Q1 		$261K Buy
15,000
+2,778
+23% +$41.4K ﹤0.01% 2035
2018
Q4 		$167K Buy
12,222
+2,255
+23% +$39.7K ﹤0.01% 2160
2018
Q3 		$214K Buy
9,967
+4,378
+78% +$133K ﹤0.01% 2065
2018
Q2 		$239K Buy
5,589
+878
+19% +$40.2K ﹤0.01% 2164
2018
Q1 		$307K Buy
4,711
+1,022
+28% +$72.4K ﹤0.01% 2003
2017
Q4 		$269K Buy
+3,689
New +$305K ﹤0.01% 1983
2015
Q1 		– Sell
-2,989
Closed -$1.07M – 2463
2014
Q4 		$1.07M Buy
+2,989
New +$890K 0.01% 1137

Other funds holding LUMO

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers's LUMO Position: Q2 2024 in Review

Two Sigma Advisers sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2024, closing a stake of 31,900 shares — an estimated $90K sold.

Two Sigma Advisers first reported a position in LUMO in Q4 2014 and held it in 16 quarters. The position peaked at $1.07M in Q4 2014. 35 funds tracked by Wall St. Rank hold LUMO as of Q2 2024.

  • Two Sigma Advisers reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 31,900 Lumos Pharma, Inc. Common Stock shares in Q2 2024, an estimated $90K.
  • Two Sigma Advisers first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 16 quarters.
  • Two Sigma Advisers's Lumos Pharma, Inc. Common Stock position peaked at $1.07M in Q4 2014.
  • 35 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2024.

Based on Two Sigma Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.